Biopharmaceuticals – i.e. protein based drugs – are one of the fastet growing type of drugs and expertise on the industrial production will be increasingly sought off. Thus Redbiotec started a collaboration with the department of Prof. Dr. Thierry Voléry from the University of St. Gallen in the form of a master thesis.In the next 6 month to come current industrial production processes will be systematically analysed upon optimization potential through the leading baculovirus technology of redbiotec.
